Recent Finacing
Recent Raise
Biomica is a clinical-stage biopharmaceutical company developing microbiome-based therapeutics using a Computational Predictive Biology platform to advance programs targeting antibiotic-resistant bacteria, immuno-oncology, and GI disorders, including BMC128 and BMC333.